CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomics and personalized medicine.
083790 | KO
Overview
Corporate Details
- ISIN(s):
- KR7083790006
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙8로 38 마곡동, 강서구
- Website:
- https://cginvites.com/en
- Sector:
- Manufacturing
Description
CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-11-27 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.1 KB | ||
| 2019-11-27 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.2 KB | ||
| 2019-11-14 00:00 |
분기보고서 (2019.09)
|
Korean | 1.6 MB | ||
| 2019-11-11 00:00 |
타법인주식및출자증권취득결정(씨지바이오사이언스 주식회사 설립)
|
Korean | 28.8 KB | ||
| 2019-11-04 00:00 |
기타경영사항(특허권취득)(자율공시)(경피흡수제제)
|
Korean | 5.2 KB | ||
| 2019-10-31 00:00 |
기타경영사항(자율공시)(아셀렉스정2밀리그램(폴마콕시브) 의약품 제조판매품목 허가 획득)
|
Korean | 5.7 KB | ||
| 2019-09-24 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.7 KB | ||
| 2019-09-02 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.1 KB | ||
| 2019-09-02 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.1 KB | ||
| 2019-08-30 00:00 |
기타경영사항(자율공시)(항생제 내성 미생물(슈퍼박테리아)에 의한 감염증 치료제 CG-549의 임상1상 시험 계획 승인)
|
Korean | 7.6 KB | ||
| 2019-08-14 00:00 |
반기보고서 (2019.06)
|
Korean | 1.9 MB | ||
| 2019-08-13 00:00 |
[기재정정]사업보고서 (2018.12)
|
Korean | 1.9 MB | ||
| 2019-08-09 00:00 |
기타경영사항(자율공시)(섬유화증 치료제 CG-750의 임상1상 시험 계획 승인)
|
Korean | 7.8 KB | ||
| 2019-08-07 00:00 |
전환가액의조정(제12회차)
|
Korean | 12.8 KB | ||
| 2019-08-07 00:00 |
신주인수권행사가액의조정(제13회차)
|
Korean | 13.1 KB |
Automate Your Workflow. Get a real-time feed of all CG Invites Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CG Invites Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CG Invites Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
